Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signaling, as a novel molecular targeted therapy against cholangiocarcinoma

4663

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

https://asahikawa-med.repo.nii.ac.jp/record/3940/files/4663.pdf

application/pdf

ファイル	ライセンス
4663.pdf (273.4 kB) sha256 61ac966c168c04459a048364fb2ff791edf5037cc2893a2812961fb5d83dcc1c

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays